Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof

US Patent 10526382 · Granted Jan 7, 2020

Estimated economic value: $1,631,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins specific for CD137 and GPC32025
Fusion proteins specific for CD137 and GPC32025
Proteins specific for CD1372025
Proteins specific for CD1372025
Proteins specific for CD1372025
Proteins specific for CD1372025
Methods for evaluating therapeutic benefit of combination therapies2024
Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC2024
Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC2024
Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC2024
Lipocalin muteins with binding affinity for LAG-32023
Lipocalin muteins with binding affinity for LAG-32023